Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT

User menu

Search

  • Advanced search
eNeuro
eNeuro

Advanced Search

 

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT
PreviousNext
New Research, Disorders of the Nervous System

Nuclear receptor Nr4a1 regulates striatal striosome development and dopamine D1 receptor signaling

M. D. Cirnaru, C. Melis, T. Fanutza, S. Naphade, K. N Tshilenge, B. S. Muntean, K. A. Martemyanov, J. L. Plotkin, L. M. Ellerby and M. E Ehrlich
eNeuro 20 September 2019, ENEURO.0305-19.2019; https://doi.org/10.1523/ENEURO.0305-19.2019
M. D. Cirnaru
1Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C. Melis
1Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for C. Melis
T. Fanutza
1Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. Naphade
2The Buck Institute for Research on Aging, Novato, CA 94945, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K. N Tshilenge
2The Buck Institute for Research on Aging, Novato, CA 94945, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
B. S. Muntean
3Department of Neuroscience, The Scripps Research Institute, Jupiter, FL 33458, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K. A. Martemyanov
3Department of Neuroscience, The Scripps Research Institute, Jupiter, FL 33458, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for K. A. Martemyanov
J. L. Plotkin
4Department of Neurobiology and Behavior, Stony Brook Univ., Stony Brook, NY 11794, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
L. M. Ellerby
2The Buck Institute for Research on Aging, Novato, CA 94945, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. E Ehrlich
1Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

The GABAergic medium-size spiny neuron (MSN), the striatal output neuron, may be classified into striosome, also known as patch, and matrix, based on neurochemical differences between the two compartments. Up to date, little is known regarding the regulation of development of the two compartments. Nr4a1, primarily described as a nuclear receptor/immediate early gene involved in the homeostasis of the dopaminergic system, is a striosomal marker. Using Nr4a1 overexpressing and null mice, we sought to determine whether Nr4a1 is necessary and/or sufficient for striosome development. We report that in vivo and in vitro, Nr4a1 and Oprm1 mRNA levels are correlated. In the absence of Nr4a, there is a decrease in the percentage of striatal surface area occupied by striosomes. Alterations in Nr4a1 expression leads to dysregulation of multiple mRNAs of members of the dopamine receptor D1 signal transduction system. Constitutive overexpression of Nr4a1 decreases both the induction of phosphorylation of map kinase (ERK) after a single cocaine exposure and locomotor sensitization following chronic cocaine exposure. Nr4a1 overexpression increases MSN excitability but reduces MSN long-term potentiation (LTP). In the resting state, adenylyl cyclase V (ACV) activity is normal, but the ability of ACV to be activated by Drd1 G-protein coupled receptor inputs is decreased. Our results support a role for Nr4a1 in determination of striatal patch/matrix structure and in regulation of dopaminoceptive neuronal function.

Significance statement This study provides insight on the role of Nr4a1, a transcription factor belonging to the family of orphan nuclear receptors Nurr, in the development of the striatal striosomal compartment and in the regulation of dopaminoceptive neuronal function. We show that alteration of Nr4a1 expression impacts the expression of striosome markers in vivo and in vitro, suggesting that Nr4a1 is necessary for full striosome development. Moreover, Nr4a1 overexpression alters Drd1 signal transduction at multiple levels resulting in reduced phosphorylation of ERK after cocaine, reduced induction of LTP, and absence of locomotor sensitization following chronic cocaine. These results indicate that the pathways regulated by Nr4a1 may represent novel, druggable approaches to pathological states such as levodopa induced dyskinesia and cocaine sensitization.

  • dopamine receptor D1
  • ERK
  • Nr4a1
  • signal
  • striosome
  • transduction

Footnotes

  • The authors declare no competing financial interests.

  • Collaborative center for X linked Dystonia Parkinsonim; HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS) [R01NS100529].

This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.

Back to top
Email

Thank you for sharing this eNeuro article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Nuclear receptor Nr4a1 regulates striatal striosome development and dopamine D1 receptor signaling
(Your Name) has forwarded a page to you from eNeuro
(Your Name) thought you would be interested in this article in eNeuro.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
View Full Page PDF
Citation Tools
Nuclear receptor Nr4a1 regulates striatal striosome development and dopamine D1 receptor signaling
M. D. Cirnaru, C. Melis, T. Fanutza, S. Naphade, K. N Tshilenge, B. S. Muntean, K. A. Martemyanov, J. L. Plotkin, L. M. Ellerby, M. E Ehrlich
eNeuro 20 September 2019, ENEURO.0305-19.2019; DOI: 10.1523/ENEURO.0305-19.2019

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Nuclear receptor Nr4a1 regulates striatal striosome development and dopamine D1 receptor signaling
M. D. Cirnaru, C. Melis, T. Fanutza, S. Naphade, K. N Tshilenge, B. S. Muntean, K. A. Martemyanov, J. L. Plotkin, L. M. Ellerby, M. E Ehrlich
eNeuro 20 September 2019, ENEURO.0305-19.2019; DOI: 10.1523/ENEURO.0305-19.2019
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • dopamine receptor D1
  • ERK
  • Nr4a1
  • signal
  • striosome
  • transduction

Responses to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

New Research

  • A Very Fast Time Scale of Human Motor Adaptation: Within Movement Adjustments of Internal Representations during Reaching
  • TrkB Signaling Influences Gene Expression in Cortistatin-Expressing Interneurons
  • Optogenetic Activation of β-Endorphin Terminals in the Medial Preoptic Nucleus Regulates Female Sexual Receptivity
Show more New Research

Disorders of the Nervous System

  • The PDGFBB-PDGFRβ Pathway and Laminins in Pericytes Are Involved in the Temporal Change of AQP4 Polarity during Temporal Lobe Epilepsy Pathogenesis
  • The Ventral Pallidum Innervates a Distinct Subset of Midbrain Dopamine Neurons
  • Rethinking Alzheimer's: Harnessing Cannabidiol to Modulate IDO and cGAS Pathways for Neuroinflammation Control
Show more Disorders of the Nervous System

Subjects

  • Disorders of the Nervous System
  • Home
  • Alerts
  • Follow SFN on BlueSky
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Latest Articles
  • Issue Archive
  • Blog
  • Browse by Topic

Information

  • For Authors
  • For the Media

About

  • About the Journal
  • Editorial Board
  • Privacy Notice
  • Contact
  • Feedback
(eNeuro logo)
(SfN logo)

Copyright © 2025 by the Society for Neuroscience.
eNeuro eISSN: 2373-2822

The ideas and opinions expressed in eNeuro do not necessarily reflect those of SfN or the eNeuro Editorial Board. Publication of an advertisement or other product mention in eNeuro should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in eNeuro.